Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2020 2
2021 2
2022 2
2023 1
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Implications of disease-modifying therapies for multiple sclerosis on immune cells and response to COVID-19 vaccination.
Orrù V, Serra V, Marongiu M, Lai S, Lodde V, Zoledziewska M, Steri M, Loizedda A, Lobina M, Piras MG, Virdis F, Delogu G, Marini MG, Mingoia M, Floris M, Masala M, Castelli MP, Mostallino R, Frau J, Lorefice L, Farina G, Fronza M, Carmagnini D, Carta E, Pilotto S, Chessa P, Devoto M, Castiglia P, Solla P, Zarbo RI, Idda ML, Pitzalis M, Cocco E, Fiorillo E, Cucca F. Orrù V, et al. Among authors: carmagnini d. Front Immunol. 2024 Jul 15;15:1416464. doi: 10.3389/fimmu.2024.1416464. eCollection 2024. Front Immunol. 2024. PMID: 39076966 Free PMC article.
Cannabinoids and dystonia: an issue yet to be defined.
Mascia MM, Carmagnini D, Defazio G. Mascia MM, et al. Among authors: carmagnini d. Neurol Sci. 2020 Apr;41(4):783-787. doi: 10.1007/s10072-019-04196-5. Epub 2019 Dec 17. Neurol Sci. 2020. PMID: 31848779 Review.
Cross-sectional analysis of the humoral response after SARS-CoV-2 vaccination in Sardinian multiple sclerosis patients, a follow-up study.
Idda ML, Pitzalis M, Lodde V, Loizedda A, Frau J, Lobina M, Zoledziewska M, Virdis F, Delogu G, Marini MG, Mingoia M, Masala M, Lorefice L, Fronza M, Carmagnini D, Carta E, Pilotto S, Castiglia P, Chessa P, Uzzau S, Farina G, Solla P, Steri M, Devoto M, Fiorillo E, Floris M, Zarbo RI, Cocco E, Cucca F. Idda ML, et al. Among authors: carmagnini d. Front Immunol. 2022 Aug 18;13:946356. doi: 10.3389/fimmu.2022.946356. eCollection 2022. Front Immunol. 2022. PMID: 36059537 Free PMC article.
Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it?
Schiavetti I, Inglese M, Frau J, Signoriello E, Caleri F, Stromillo ML, Ferrò MT, Rilla MT, Gandoglia I, Gazzola P, Brichetto G, Pasquali L, Grimaldi L, Ulivelli M, Marinelli F, Cordera S, Clerico M, Conte A, Salvetti M, Battaglia MA, Franciotta D, Uccelli A, Sormani MP; CovaXiMS Study Group. Schiavetti I, et al. Eur J Neurol. 2023 Aug;30(8):2357-2364. doi: 10.1111/ene.15830. Epub 2023 May 28. Eur J Neurol. 2023. PMID: 37154406 Free article.
Effect of Different Disease-Modifying Therapies on Humoral Response to BNT162b2 Vaccine in Sardinian Multiple Sclerosis Patients.
Pitzalis M, Idda ML, Lodde V, Loizedda A, Lobina M, Zoledziewska M, Virdis F, Delogu G, Pirinu F, Marini MG, Mingoia M, Frau J, Lorefice L, Fronza M, Carmagnini D, Carta E, Orrù V, Uzzau S, Solla P, Loi F, Devoto M, Steri M, Fiorillo E, Floris M, Zarbo IR, Cocco E, Cucca F. Pitzalis M, et al. Among authors: carmagnini d. Front Immunol. 2021 Dec 9;12:781843. doi: 10.3389/fimmu.2021.781843. eCollection 2021. Front Immunol. 2021. PMID: 34956211 Free PMC article.
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies.
Sormani MP, Inglese M, Schiavetti I, Carmisciano L, Laroni A, Lapucci C, Da Rin G, Serrati C, Gandoglia I, Tassinari T, Perego G, Brichetto G, Gazzola P, Mannironi A, Stromillo ML, Cordioli C, Landi D, Clerico M, Signoriello E, Frau J, Ferrò MT, Di Sapio A, Pasquali L, Ulivelli M, Marinelli F, Callari G, Iodice R, Liberatore G, Caleri F, Repice AM, Cordera S, Battaglia MA, Salvetti M, Franciotta D, Uccelli A; CovaXiMS study group on behalf of the Italian Covid-19 Alliance in MS. Sormani MP, et al. EBioMedicine. 2021 Oct;72:103581. doi: 10.1016/j.ebiom.2021.103581. Epub 2021 Sep 22. EBioMedicine. 2021. PMID: 34563483 Free PMC article.
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy.
Sormani MP, Schiavetti I, Inglese M, Carmisciano L, Laroni A, Lapucci C, Visconti V, Serrati C, Gandoglia I, Tassinari T, Perego G, Brichetto G, Gazzola P, Mannironi A, Stromillo ML, Cordioli C, Landi D, Clerico M, Signoriello E, Cocco E, Frau J, Ferrò MT, Di Sapio A, Pasquali L, Ulivelli M, Marinelli F, Pizzorno M, Callari G, Iodice R, Liberatore G, Caleri F, Repice AM, Cordera S, Battaglia MA, Salvetti M, Franciotta D, Uccelli A; CovaXiMS study group. Sormani MP, et al. EBioMedicine. 2022 Jun;80:104042. doi: 10.1016/j.ebiom.2022.104042. Epub 2022 May 5. EBioMedicine. 2022. PMID: 35526306 Free PMC article.